Navigation Links
Spot On Sciences Awarded $1 Million DARPA Grant to Develop a Blood Sample Collection Device

AUSTIN, Texas, June 25, 2012 /PRNewswire-iReach/ -- Spot On Sciences, Inc., an Austin-based medical device company, has received a two-year, $1 million Small Business Innovation Research (SBIR) Phase II award from the Defense Advanced Research Projects Agency (DARPA) to further develop a device that would allow anyone to take a blood sample in any location and ship or store the samples at room temperature.

The HemaSpot™ device, developed by scientists at Spot On Sciences under a DARPA SBIR Phase I award, is based on dried blood spot (DBS) technology, which is best known for newborn screening.  The patented device allows blood sample collection to be performed away from a lab, improves sample quality, simplifies collection, and allows for stable sample storage for years at room temperature.  Recognizing the potential of the HemaSpot™ device for improving point-of-care diagnostic testing of military personnel, DARPA is supporting further research. 

"We are excited to be working with DARPA to develop a device that is robust enough to allow a soldier in the field to safely collect blood for testing" said Dr. Jeanette Hill, Spot On Sciences' Chief Executive Officer.   "HemaSpot™ has many additional commercial uses for clinical trials, rural and home-bound testing, bio-banking, population studies and a wide range of medical research."

The single-use HemaSpot™ device uses a finger stick to collect and dry two drops of blood within a protective cartridge.  Once dried, the sample is stable at room temperature and can be safely and easily shipped to a diagnostic test site for analysis.  Traditional DBS involves a multi-step process that is subject to errors from moisture, contamination, and sample loss.  HemaSpot's™ innovative design addresses these problems, streamlining the entire process.  Common disease markers can be measured including proteins, nucleic acids and small molecules. 

"Traditional testing by venipuncture draws several vials of blood. HemaSpot™ takes a tiny sample, only two drops, and spreads it onto a filter paper which we have pre-cut into fan blades that can be easily 'plucked' for analysis. They also remain stable at room temperature for years. The real advantage of this technology," continued Dr. Hill, "is that it is much easier and cheaper  to collect and store blood samples. This creates exciting new possibilities for medical research and health care."

About Spot On Sciences

Spot On Sciences, Inc., located in Austin, Texas, is a medical device company that is actively developing innovative methods for collecting and storing biological fluid samples.  The company's current product, HemaSpot™, allows for simplified blood sample collection and storage for dried blood spot (DBS) testing.  More than 20 billion blood tests are performed annually worldwide with in vitro diagnostics showing sales of an estimated US$28.6 billion worldwide.  Spot On Sciences aspires to change existing paradigms in this mature market with technologies that simplify processes, save time and reduce costs.  The firm was selected in 2011 as a finalist for the prestigious Cartier Women's Initiative Award.  For more information visit the company's website at

Media Contact: Susan Leininger Spot On Sciences, Inc, 512-836-8012,

News distributed by PR Newswire iReach:

SOURCE Spot On Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Indiana leads U.S. in life sciences jobs and growth
2. Oriel STAT A MATRIX Welcomes New Global Practice Head for Medical Devices and Life Sciences
3. Particle Sciences Expands its cGMP Capabilities with the Addition of Thin Films
4. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
5. USANA Health Sciences Expands Award-Winning Research and Development Team
6. BIOCRATES Life Sciences to Launch Waters Xevo® TQ MS Editions for Two of its Well-established Research Kit Products, AbsoluteIDQ® p180 and p150
7. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
8. Egalet to Present at Life Sciences Europe Conference
9. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
10. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
11. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
Post Your Comments:
(Date:11/24/2015)... 24, 2015 F1000Workspace - a ... since it was launched just six months ago. --> ... authoring platform for scientists - since it was launched just ... been loaded on to F1000Workspace - a research ... it was launched just six months ago. ...
(Date:11/24/2015)... Nov. 24, 2015 iRhythm Technologies, Inc. , a ... today announced that it will participate in the 27th Annual Piper ... New York, NY . Kevin King , ... December 1, 2015 at 8:50am ET. --> ... . --> . --> iRhythm ...
(Date:11/24/2015)... uptake of recently approved and pipeline premium products for Type 1 Diabetes ... says GBI Research . --> The ... Mellitus (T1DM), will be a key driver of market growth to 2021, ... The uptake of recently approved and pipeline premium products for Type 1 ... 2021, says GBI Research . Type ...
Breaking Medicine Technology:
(Date:11/24/2015)... VA (PRWEB) , ... November 24, 2015 , ... ... people across the United States to support their local poison centers through donations ... designated as #GivingTuesday: calls it “a day that inspires people to collaborate ...
(Date:11/24/2015)... ... 24, 2015 , ... Serenity Point Rehabilitation, a holistic treatment center for substance ... some of the staff members at their recovery center. The videos highlight some of ... some of the things that make their recovery program so unique. , “Making the ...
(Date:11/24/2015)... , ... November 24, 2015 , ... Aided by seed ... announced an innovative study designed to yield insights into how to detect and treat ... biomarkers for pancreatic cancer from small, non-coding RNA molecules (ncRNA), genetic material that is ...
(Date:11/24/2015)... ... 2015 , ... Abington Hospital – Jefferson Health is pleased ... Surgery Facility for treating individuals living with morbid or extreme obesity. , Aetna ... its members to help them make informed decisions about their healthcare needs. In ...
(Date:11/24/2015)... ... 2015 , ... Dr. Rodney E. Willey , has answered a new calling – to ... Disorders, provides treatment for snoring and sleep apnea through oral appliance therapy. ... Sleep Disorders in the US, one of four in the Illinois area. , Dr. ...
Breaking Medicine News(10 mins):